Paul is a specialist in the biotechnology and life sciences field with particular expertise in synthetic biology, antibodies, antibody fragments and single-domain binding molecules such as scFv and VNARs, nucleic acid sequencing technologies, biosensors, and microfluidic devices.
Paul has a particular interest in cross-disciplinary technologies, which stems from his doctoral research at Imperial College London. This involved the characterisation of engineered electron transfer proteins with a view to their use in electrochemical biosensors and bioreactors. It was during his PhD that he first became aware of the important role that intellectual property rights play in the commercialisation of academic research.
Paul’s clients range from start-ups to large multinational corporations and universities. He has particular experience in working directly with inventors to identify patentable elements of their research, preparing new patent applications and in coordinating the prosecution of complex patent portfolios in multiple jurisdictions. In addition to his prosecution practice, Paul also has experience in the conduct of due diligence and freedom to operate exercises and is regularly involved in post-grant opposition procedures before the European Patent Office. Paul also has experience in the registration of plant variety rights.
Paul prides himself on providing pragmatic, commercially-minded advice, tailoring his guidance to suit each client.
European Patent Attorney
Chartered UK Patent Attorney
IP Litigator - Patent
Ph.D. (Biochemistry) – Imperial College London
B.Sc. with First Class Honours (Biochemistry) – Imperial College London
Chartered Institute of Patent Attorneys (CIPA)
The Institute of Professional Representatives before the European Patent Office (EPI)
D. Bernard, P. Broscoe, Novelty of overlapping ranges before the UK Courts - Jushi v OCV, Kilburn & Strode, (2019)